Evidence map›Paper›PMID 34082786›Full record

ArticleGenome biology2021

Dynamics of alternative splicing during somatic cell reprogramming reveals functions for RNA-binding proteins CPSF3, hnRNP UL1, and TIA1.

Claudia Vivori, Panagiotis Papasaikas, Ralph Stadhouders, Bruno Di Stefano, Anna Ribó Rubio, Clara Berenguer Balaguer, Serena Generoso, Anna Mallol, José Luis Sardina, Bernhard Payer and 2 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Feasibility of repairing skin defects by VEGFJournal of cellular and molecular medicine · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Dynamic alternative polyadenylation during iPSC differentiation into cardiomyocytes.Computational and structural biotechnology journal · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 5 countries.

Claudia VivoriCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Carrer del Dr. Aiguader 88, 08003, Barcelona, Spain.ORCID 0000-0001-7008-0593
Panagiotis PapasaikasCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Carrer del Dr. Aiguader 88, 08003, Barcelona, Spain.ORCID 0000-0002-1640-7636
Ralph StadhoudersCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Carrer del Dr. Aiguader 88, 08003, Barcelona, Spain.ORCID 0000-0002-1060-5607
Bruno Di StefanoCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Carrer del Dr. Aiguader 88, 08003, Barcelona, Spain.ORCID 0000-0003-2532-3087
Anna Ribó RubioCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Carrer del Dr. Aiguader 88, 08003, Barcelona, Spain.ORCID 0000-0001-6669-9959
Clara Berenguer BalaguerCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Carrer del Dr. Aiguader 88, 08003, Barcelona, Spain.
Serena GenerosoCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Carrer del Dr. Aiguader 88, 08003, Barcelona, Spain.ORCID 0000-0002-2733-1710
Anna MallolCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Carrer del Dr. Aiguader 88, 08003, Barcelona, Spain.ORCID 0000-0001-7366-0980
José Luis SardinaCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Carrer del Dr. Aiguader 88, 08003, Barcelona, Spain.ORCID 0000-0002-8493-3937
Bernhard PayerCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Carrer del Dr. Aiguader 88, 08003, Barcelona, Spain.ORCID 0000-0002-4694-2082
Thomas GrafCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Carrer del Dr. Aiguader 88, 08003, Barcelona, Spain.ORCID 0000-0003-2774-4117
Juan ValcárcelCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Carrer del Dr. Aiguader 88, 08003, Barcelona, Spain. juan.valcarcel@crg.eu.ORCID 0000-0001-5398-3571
Universitat Pompeu Fabra · ESCentre for Genomic Regulation · ESJosep Carreras Leukaemia Research Institute · ESBaylor College of Medicine · USErasmus MC · NLInstitució Catalana de Recerca i Estudis Avançats · ESSIB Swiss Institute of Bioinformatics · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSomatic cell reprogramming is the process that allows differentiated cells to revert to a pluripotent state. In contrast to the extensively studied rewiring of epigenetic and transcriptional programs required for reprogramming, the dynamics of post-transcriptional changes and their associated regulatory mechanisms remain poorly understood. Here we study the dynamics of alternative splicing changes occurring during efficient reprogramming of mouse B cells into induced pluripotent stem (iPS) cells and compare them to those occurring during reprogramming of mouse embryonic fibroblasts.

resultsWe observe a significant overlap between alternative splicing changes detected in the two reprogramming systems, which are generally uncoupled from changes in transcriptional levels. Correlation between gene expression of potential regulators and specific clusters of alternative splicing changes enables the identification and subsequent validation of CPSF3 and hnRNP UL1 as facilitators, and TIA1 as repressor of mouse embryonic fibroblasts reprogramming. We further find that these RNA-binding proteins control partially overlapping programs of splicing regulation, involving genes relevant for developmental and morphogenetic processes.

conclusionsOur results reveal common programs of splicing regulation during reprogramming of different cell types and identify three novel regulators of this process and their targets.

Indexed as

Alternative SplicingAnimalsB-LymphocytesCCAAT-Enhancer-Binding ProteinsCellular ReprogrammingCleavage And Polyadenylation Specificity FactorEmbryo, MammalianFibroblastsGene Expression Regulation, DevelopmentalHeterogeneous-Nuclear RibonucleoproteinsMiceT-Cell Intracellular Antigen-1CCAAT-Enhancer-Binding ProteinsCEBPA protein, mouseCleavage And Polyadenylation Specificity FactorCpsf3 protein, mouseHeterogeneous-Nuclear RibonucleoproteinsHnrnpul1 protein, mouseT-Cell Intracellular Antigen-1Alternative splicingCPSF3hnRNP UL1PluripotencySomatic cell reprogrammingTIA1

Identifiers

PMID34082786
PMCPMC8173870
OpenAlexW3164028935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.